Tissue Bioavailability

Tissue Bioavailability is a pharmacokinetic construct that denotes the extent and rate at which an administered drug reaches a specific target tissue in a biologically active form, distinguishing it from systemic bioavailability by emphasizing localized tissue exposure rather than general circulation.

277

Publications

14.5K

Citations

1.6K

Authors

508

Institutions

Publications per year

2017–2026

82

Authors

1.6K

  1. MH
    Masaki Honda

    Meijo University, Japan

    3 publications · 120 citations

    3

    h-index

  2. RC
    Ramesh C. Gupta

    University of Louisville, United States

    2 publications · 344 citations

    2

    h-index

  3. JH
    Jean H. Rapley

    Syngenta (United Kingdom), United Kingdom

    2 publications · 203 citations

    2

    h-index

  4. KX
    Kang Xu

    DEVCOM Army Research Laboratory, United States

    2 publications · 114 citations

    2

    h-index

  5. QL
    Qiuhong Li

    University of Florida, United States

    2 publications · 114 citations

    2

    h-index

1–5 of 1.6K

Venues

  1. Journal of Agricultural and Food Chemistry

    11 publications · 932 citations

    11

    h-index

  2. PubMed

    Repository · 10 publications · 433 citations

    10

    h-index

  3. Environmental Toxicology and Chemistry

    8 publications · 451 citations

    8

    h-index

  4. Environmental Science & Technology

    7 publications · 520 citations

    7

    h-index

  5. Poultry Science

    5 publications · 244 citations

    6

    h-index

1–5